Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

A Study to Evaluate the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

ClinicalTrials.gov ID: NCT05366751

Public ClinicalTrials.gov record NCT05366751. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 9:45 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study of the Long-term Safety and Tolerability of SAGE-324 in Participants With Essential Tremor

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary purpose of this study is to evaluate the long-term safety and tolerability of SAGE-324 in participants with essential tremor (ET).

Study identification

NCT ID
NCT05366751
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Sage Therapeutics
Industry
Enrollment
97 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 2, 2022
Primary completion
Sep 9, 2024
Completion
Sep 9, 2024
Last update posted
Jul 31, 2025

2022 – 2024

United States locations

U.S. sites
38
U.S. states
19
U.S. cities
35
Facility City State ZIP Site status
Sage Investigational Site Hoover Alabama 35244
Sage Investigational Site Scottsdale Arizona 85258
Sage Investigational Site Fountain Valley California 92708
Sage Investigational Site Fullerton California 92835
Sage Investigational Site Los Angeles California 90095
Sage Investigational Site Englewood Colorado 80113
Sage Investigational Site Boca Raton Florida 33486
Sage Investigational Site Bradenton Florida 34205
Sage Investigational Site Coral Springs Florida 33067
Sage Investigational Site Hollywood Florida 33024
Sage Investigational Site Miami Florida 33136
Sage Investigational Site Miami Florida 33175
Sage Investigational Site Miami Florida 33176
Sage Investigational Site Naples Florida 34105
Sage Investigational Site Orlando Florida 32803
Sage Investigational Site Tampa Florida 33612
Sage Investigational Site Atlanta Georgia 30329
Sage Investigational Site Decatur Georgia 30030
Sage Investigational Site Kansas City Kansas 66160
Sage Investigational Site Lexington Kentucky 40509
Sage Investigational Site Shreveport Louisiana 71105
Sage Investigational Site Boston Massachusetts 02131
Sage Investigational Site Farmington Hills Michigan 48334
Sage Investigational Site New York New York 10003
Sage Investigational Site New York New York 10032
Sage Investigational Site Asheville North Carolina 28806
Sage Investigational Site Cincinnati Ohio 45219
Sage Investigational Site Dayton Ohio 45417
Sage Investigational Site Tulsa Oklahoma 74136
Sage Investigational Site Memphis Tennessee 38157
Sage Investigational Site Austin Texas 78746
Sage Investigational Site Fort Worth Texas 76104
Sage Investigational Site Houston Texas 77030
Sage Investigational Site Katy Texas 77450
Sage Investigational Site Round Rock Texas 78681
Sage Investigational Site West Falls Church Virginia 22042
Sage Investigational Site Kirkland Washington 12039
Sage Investigational Site Spokane Washington 99202

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05366751, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2025 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05366751 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →